期刊文献+

EBV与非霍奇金淋巴瘤的相关性研究 被引量:1

Study on the correlation between EBV and NHL
暂未订购
导出
摘要 目的探讨EBV与非霍奇金淋巴瘤的相关性。方法采用免疫荧光法检测62例非霍奇金淋巴瘤患者外周血血清中EBV-VCA-IGA,进而探讨EBV感染与非霍奇金淋巴瘤的相关性。结果92例非霍奇金淋巴瘤患者EBV-VCA-IGA阳性率为36%,B细胞来源非霍奇金淋巴瘤患者EBV-VCA-IGA阳性率为34%,T细胞来源非霍奇金淋巴瘤患者EBV-VCA-IGA阳性率为38%。结论EBV与非霍奇金淋巴瘤关系密切,监测EBV感染状况,对非霍奇金淋巴瘤的早期诊断及预后判断具有重要意义。 Objective To discusse a study on the relationship between EBV and NHL. Methods Immunoflt, rescent method was used in measuring the EBV-VCA-IGA in peripheral blood serum of 62 NHL patients, so as to further investigate the correlation between EBV and NHL. Results 92 cases of NHL patients, 36% taked on positive for EBV-VCA-IGA and in B-cell NHL patients, the proportion was 34%, while in T-cell NHL patients, the proportion was 38%. Conclusion Here a tentative conclusion is drawn that EBV is closely related to NHL. Monitoring EBV infection state has proved to be very important for an early diagnosis and more precise prognosis prediction to NHL patients.
出处 《中国微生态学杂志》 CAS CSCD 2007年第4期370-371,共2页 Chinese Journal of Microecology
关键词 EBV 非霍奇金淋巴瘤 相关性 EBV NHL Relationship
  • 相关文献

参考文献4

二级参考文献17

  • 1刘振声,李宝民,刘彦仿,曾毅.EB病毒反义LMP1基因对人低分化鼻咽癌CNE-3细胞株生长的抑制作用[J].中华耳鼻咽喉科杂志,1996,31(2):92-95. 被引量:9
  • 2高子芬,李继刚,侯亮,李宁,杜娟,廖松林.非鼻咽部T细胞淋巴瘤与EB病毒的相关性[J].北京医科大学学报,1997,29(2):103-104. 被引量:8
  • 3Harris NL ,Jaffe ES,Diebold J ,et al. The World Health Organization of neoplastic dieases of the haematopoietie and lymphoid tissues:report of the Clinical Advisor Committee Meeting ,Airlie House ,Virginia , November 1997 [J]. Histopathology , 2000, 36: 69-87.
  • 4Jaffe ES,Chan J KC ,Su LJ,et al. Report of the wordshop onnasal and related extranodal angiocentric T/Nature killer cell lymphoman[J]. Am J Surg Pathol , 1996,20 : 103.
  • 5Ragoczy T, Heston L, Miller G. The Epstein-Barr virus Rta protein activates lyric cycle genes and can disrupt latency in B lymphoeytes[J]. J Virol, 1998, 72(10): 7978-7984.
  • 6Westphal EW, Blackstock W, Feng W, et al. Activation of lytic Epstein-Barr virus (EBV) infection by radiation and sodium butyrate in vitro and in vivo: a potential method for treating EBV-positive malignancies[J]. Cancer Res, 2000, 60(20): 5781-5788.
  • 7Morre SM, Cannon JS, Tanhehco YC, et al. Induction of epstein-barr virus kinases to sensitize tumor cells to nucleoside analogues[J]. Antimicrob Agents Chemother, 2001, 45(7): 2082-2091.
  • 8Westphal EW, Mauser A, Swenson J, et at. Induction of lyric Epstein-Barr virus infection in EBV-associated malignancies use in adenovirus vectors in vitro and in vivo[J]. Cancer Res, 1999, 59(7): 1485-1491.
  • 9Sunita Z, Elizabeth HG. Epstein-Barr viral latency is disrupted by the immediate early BRLF1 protein through a cell specific mechanism[J]. Proc Natl Acad Sci USA, 1996, 93(17): 9194-9199.
  • 10John LY, Sarah MC, Jacqueline MB. The minimal replicator of Eptein-Barr virus orip[J]. J Virol, 2000, 74(10): 4512-4522.

共引文献8

同被引文献14

引证文献1

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部